Viracta Therapeutics
VIRX
#10165
Rank
C$9.72 M
Marketcap
$0.24
Share price
-6.06%
Change (1 day)
-63.73%
Change (1 year)

Earnings for Viracta Therapeutics (VIRX)

Earnings in 2024 (TTM): -C$58.36 Million

According to Viracta Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$73.94 Million a decrease over its 2022 earnings that were of -C$71.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viracta Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$58.36 Million-21.07%
2023 -C$73.94 Million3.78%
2022 -C$71.24 Million-57.13%
2021 -C$0.17 Billion503.47%
2020 -C$27.54 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.2 Billion 211.29%๐Ÿ‡บ๐Ÿ‡ธ USA